Article Text

Download PDFPDF
The need for personalised medicine for rheumatoid arthritis
  1. John D Isaacs1,
  2. Gianfranco Ferraccioli2
  1. 1Institute of Cellular Medicine, Musculoskeletal Research Group, Newcastle University, Newcastle, UK
  2. 2Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy
  1. Correspondence to Professor John D Isaacs, Institute of Cellular Medicine, Musculoskeletal Research Group, 4th Floor, Catherine Cookson Building, The Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, UK; j.d.isaacs{at}ncl.ac.uk

Footnotes

  • Competing interests JDI has consulted for Hoffman La Roche and Bristol-Myers Squibb, and received educational or research grants from Centocor, Wyeth and Abbott pharmaceuticals. GFF received fees for lectures from Roche, Abbott, Wyeth, Shering Plough and grant for research support from Wyeth, BMS and Roche

  • Provenence and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests JDI has consulted for Hoffman La Roche and Bristol-Myers Squibb, and received educational or research grants from Centocor, Wyeth and Abbott pharmaceuticals. GFF received fees for lectures from Roche, Abbott, Wyeth, Shering Plough and grant for research support from Wyeth, BMS and Roche

  • Provenence and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.